Objective. Predict the main active ingredients, potential targets, and critical pathways of Tripterygium wilfordii treatment in Henoch-Schonlein purpura nephritis, and explore possible mechanisms by network pharmacology and molecular docking technology.Methods.The active ingredients and their corresponding targets of Tripterygium Wilfordii were screened based on the Traditional Chinese Medicine Systematic Pharmacology Database and Analysis Platform. Access to Henoch-Schonlein purpura nephritis targets by searching the GeneCards database, the online human Mendelian genetic database, and the DisGeNET database. The intersection targets of Tripterygium Wilfordii and Henoch-Schonlein purpura nephritis were obtained by Venn software. Construction of dynamic ingredient-target networks and protein-protein interaction networks using Cytoscape 3.7.2 software. PPI network analysis using the STRING database. Gene ontology enrichment analysis and Kyoto Encyclopedia of Genes and Genomes enrichment analysis of intersecting genes using the R cluster Profiler. Select key targets and core active ingredients, and use AutoDock software for molecular docking.Result.Network pharmacology predictions show 42 active ingredients in Tripterygium Wilfordii for the treatment of Henoch-Schonlein purpura nephritis, with the core active ingredients being triptolide, kaempferol, Isoxanthohumol. The key targets are tumor necrosis factor, interleukin 8 and matrix metalloproteinase-9, vascular endothelial growth factor A, etc. The biological processes in GO analysis are mainly concerned with response to lipopolysaccharide, response to molecule of bacterial origin, extrinsic apoptotic signaling pathway, positive regulation of peptidyl-tyrosine phosphorylation. The molecular function includes cytokine activity, cytokine receptor binding, receptor ligand activity, and signal receptor activator activity. The cell composition provides membrane rafts, membrane microdomain, external side of plasma membrane, and collagen-containing extracellular matrix. KEGG analysis obtains relevant signaling pathways as a nuclear transcription factor NF-κB, tumor necrosis factor signaling pathway, interleukin 17 signaling pathway. The molecular docking results showed that triptolide, kaempferol, and Isoxanthohumol had suitable binding activities with TGFB1, MMP9, and TNF.Conclusion.The mechanism of action of Tripterygium wilfordii in the treatment of Henoch-Schonlein purpura nephritis lies in applying active ingredients such as triptolide, kaempferol, and Isoxanthohumol, with TNF, CXCL8, MMP-9, and VEGFA as crucial targets, through NF-κB, TNF, and IL-17 signaling pathways inhibit the inflammatory response, thus play a role in the treatment of Henoch-Schonlein purpura nephritis.